Kommentar zu „Testosteron-Ersatztherapie birgt kein Risiko für kardiale Ereignisse“

• Literatur

• 1 Muraleedharan V, Marsh H, Kapoor D. et al. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol 2013; 169 (06) 725-733
• 2 Basaria S, Coviello AD, Travison TG. et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363 (02) 109-122
• 3 Snyder PJ, Bhasin S, Cunningham GR. Testosterone Trials Investigators. et al. Effects of Testosterone Treatment in Older Men. N Engl J Med 2016; 374 (07) 611-624
• 4 Corona G, Goulis DG, Huhtaniemi I. et al. Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology. Andrology 2020; 8 (05) 970-987